Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Vitamin D metabolites alphacalcidol and calcitriol (D-hormones) have been investigated for two decades, but few and conflicting results are available from high-quality randomized controlled trials. Our objectives were to provide an evidence-based update quantitatively summarizing their efficacy on bone mineral density (BMD) and fracture rate. We performed a systematic research of any randomized controlled trial containing relevant data, peer review, data extraction and quality scoring blinded for authors and data sources, and comprehensive meta-analyses of the relevant data. Inclusion criteria were: randomized controlled study, calcitriol or alphacalcidol, BMD or fractures in healthy/osteopenic/osteoporotic patients exposed or not to corticosteroids (CS). Analyses were performed in a conservative fashion using professional dedicated softwares and stratified by outcome, target patients, study quality, and control-group type. Results were expressed as effect size (ES) for bone loss or relative risk (RR) for fracture while allocated to D-hormones vs control. Publication bias and robustness were investigated. Of the trials that were retrieved and subsequently reviewed, 17 papers fitted the inclusion criteria and were assessed. Quality scores ranged from 20 to 100%, the mean (standard deviation) being 72 (22)%. Calcitriol and alphacalcidol were found to have the same efficacy on all outcomes at p>0.13. We globally assessed D-hormones effects in preventing bone loss in patients not…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For four meta-analyses, it was unclear if omission of the affected trial reports would alter the findings (Richy et al 25 79 citations, October 2018; Richy et al 26 91 citations, February 2018; Murad et al 27 26 citations, August 2018; Yang et al 28 54 citations, October 2018).”
From An investigation into the impact and implications of published papers from retracted research: systematic search of affected literature (2019) · cites this paper as [25]
Citations
Cites
2 retracted
Sato, Y., Manabe, S., Kuno, H., & Oizumi, K. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.1.64 · Cited by 131 · cited 5×
“It contained 8 studies in postmenopausal OP [40, 42, 43, 45, 48, 49, 55, 56], 1 study in healthy postmenopausal women [44], 1 study in male OP [41], and 2 studies in a mixed elderly population with neurological conditions [ 53 , 54].”
BackgroundMethodResultInfluentialRetractedSato, Y., Maruoka, H., & Oizumi, K. (1997) · Stroke · doi:10.1161/01.str.28.4.736 · Cited by 76
RetractedBias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Neer, R. M., Arnaud, C. D., Zanchetta, J. R., Prince, R., Gaich, G. A., Reginster, J.-Y., Hodsman, A. B., Eriksen, E. F., Ish-Shalom, S., Genant, H. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441904 · Cited by 4,602 · cited 1×
“The drugs with the most rigorous experimental data showing fracture reduction include the bisphosphonates, alendronate and risedronate, raloxifene, and intermittent parathyroid hormone therapy [13, 14, 15, 16, 17 ].”
BackgroundSelf-citationDong, Y., Hao, L., Shi, Z., Wang, G., Zhang, Z., & Han, C. (2013) · Urologia Internationalis · doi:10.1159/000351405 · Cited by 4,540
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gøtzsche, P. C., Lang, T., & for the CONSORT Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00012 · Cited by 3,835
Publication and related bias in meta-analysis
Sterne, J. A. C., Gavaghan, D., & Egger, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00242-0 · Cited by 2,282 · cited 1×
“Nevertheless, publication bias is not the only source of funnel plot asymmetry and this test has limited power unless a substantial bias is present [65].”
BackgroundSystematic Reviews: Identifying relevant studies for systematic reviews
Dickersin, K., Scherer, R., & Lefebvre, C. (1994) · BMJ · doi:10.1136/bmj.309.6964.1286 · Cited by 2,256
Chesnut, C. H., Silverman, S., Andriano, K., Genant, H., Gimona, A., Harris, S., Kiel, D., LeBoff, M., Maricic, M., Miller, P., et al. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00490-3 · Cited by 1,122
Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.
Abe, E., Miyaura, C., Sakagami, H., Takeda, M., Konno, K., Yamazaki, T., Yoshiki, S., & Suda, T. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.4990 · Cited by 1,020
Gallagher, J. C., Riggs, B. L., Eisman, J., Hamstra, A., Arnaud, S. B., & Deluca, H. F. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109516 · Cited by 861
Recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
American College of Rheumatology task force on Osteoporosis guidelines (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391104 · Cited by 848
Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen
Lufkin, E. G., Wahner, H. W., O'Fallon, W. M., Hodgson, S. F., Kotowicz, M. A., Lane, A. W., Judd, H. L., Caplan, R. H., & Riggs, B. L. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-1-1 · Cited by 810
Steroid-Induced Fractures and Bone Loss in Patients with Asthma
Adinoff, A. D., & Hollister, J. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308043090502 · Cited by 674
IX: Summary of Meta-Analyses of Therapies for Postmenopausal Osteoporosis
Cranney, A., Guyatt, G., Griffith, L., Wells, G., Tugwell, P., Rosen, C., The Osteoporosis Methodology Group, & The Osteoporosis Research Advisory Group (2002) · Endocrine Reviews · doi:10.1210/er.2001-9002 · Cited by 604
Treatment of Postmenopausal Osteoporosis with Calcitriol or Calcium
Tilyard, M. W., Spears, G. F. S., Thomson, J., & Dovey, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202063260601 · Cited by 575
Prediction of osteoporotic fractures by postural instability and bone density.
Nguyen, T., Sambrook, P., Kelly, P., Jones, G., Lord, S., Freund, J., & Eisman, J. (1993) · BMJ · doi:10.1136/bmj.307.6912.1111 · Cited by 568
Torgerson, D. J., & Bell-Syer, S. E. M. (2001) · JAMA · doi:10.1001/jama.285.22.2891 · Cited by 522
Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and Calcitonin
Sambrook, P., Birmingham, J., Kelly, P., Kempler, S., Nguyen, T., Pocock, N., & Eisman, J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282404 · Cited by 520
Effects of a ginger extract on knee pain in patients with osteoarthritis
Altman, R. D., & Marcussen, K. C. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200111)44:11<2531::aid-art433>3.0.co;2-j · Cited by 507
Differential effects of endocrine dysfunction on the axial and the appendicular skeleton.
Seeman, E., Wahner, H. W., Offord, K. P., Kumar, R., Johnson, W. J., & Riggs, B. L. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110570 · Cited by 463
Decline in Physical Function following Hip Fracture
Marottoli, R. A., Berkman, L. F., & Cooney, L. M. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb01980.x · Cited by 412
Glucocorticoid-Induced Osteoporosis
Baylink, D. J. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308043090509 · Cited by 402
Vitamin D Receptors: Nature and Function
Haussler, M. R. (1986) · Annual Review of Nutrition · doi:10.1146/annurev.nu.06.070186.002523 · Cited by 367
Tsai, K. S., Heath, H., Kumar, R., & Riggs, B. L. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111373 · Cited by 362
Gerlach, S. A. (1981) · Marine Pollution · doi:10.1007/978-3-642-68182-0_11 · Cited by 331
Calcitriol Treatment Is Not Effective in Postmenopausal Osteoporosis
Ott, S. M., & Chesnut, C. H. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-4-267 · Cited by 308
Vitamin D3 Receptors: Structure and Function in Transcription
Pike, J. W. (1991) · Annual Review of Nutrition · doi:10.1146/annurev.nu.11.070191.001201 · Cited by 275
Adachi, J. D., Ioannidis, G., Berger, C., Joseph, L., Papaioannou, A., Pickard, L., Papadimitropoulos, E. A., Hopman, W., Poliquin, S., Prior, J. C., et al. (2001) · Osteoporosis International · doi:10.1007/s001980170017 · Cited by 258
Impact of Hip and Vertebral Fractures on Quality-Adjusted Life Years
Tosteson, A. N. A., Gabriel, S. E., Grove, M. R., Moncur, M. M., Kneeland, T. S., & Melton III, L. J. (2001) · Osteoporosis International · doi:10.1007/s001980170015 · Cited by 239
Orimo, H., Shiraki, M., Hayashi, Y., Hoshino, T., Onaya, T., Miyazaki, S., Kurosawa, H., Nakamura, T., & Ogawa, N. (1994) · Calcified Tissue International · doi:10.1007/bf00305521 · Cited by 222
Calcitriol in the treatment of postmenopausal osteoporosis
Aloia, J. F., Vaswani, A., Yeh, J. K., Ellis, K., Yasumura, S., & Cohn, S. H. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90259-8 · Cited by 218
Gallagher, J. C., & Goldgar, D. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-9-649 · Cited by 217
Combination Treatment with Estrogen and Calcitriol in the Prevention of Age-Related Bone Loss
Gallagher, J. C., Fowler, S. E., Detter, J. R., & Sherman, S. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7703 · Cited by 216
McSheehy, P. M., & Chambers, T. J. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113089 · Cited by 214
The Nonskeletal Consequences of Osteoporotic Fractures
Gold, D. T. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70197-6 · Cited by 153
A Meta-analysis of Etidronate for the Treatment of Postmenopausal Osteoporosis
Cranney, A., Guyatt, G. H., Krolicki, N., Welch, V. A., Griffith, L. E., Adachi, J. D., Shea, B., Tugwell, P., & Wells, G. A. (2001) · Osteoporosis International · doi:10.1007/s001980170147 · Cited by 145
Richy, F. F., Bousquet, J. J., Ehrlich, G. E., Meunier, P. J., Israel, E., Morii, H., Devogelaer, J., Peel, N. F. A., Haim, M., Bruyère, O., et al. (2003) · Osteoporosis International · doi:10.1007/s00198-003-1398-z · Cited by 134
Self-citationProphylactic Use of Alfacalcidol in Corticosteroid-Induced Osteoporosis
Reginster, J., Kuntz, D., Verdickt, W., Wouters, M., Guillevin, L., Menkes, C. J., & Nielsen, K. G. (1999) · Osteoporosis International · doi:10.1007/s001980050118 · Cited by 120
Self-citationGallagher, J. C., Riggs, B. L., Recker, R. R., & Goldgar, D. (1989) · Experimental Biology and Medicine · doi:10.3181/00379727-191-42922 · Cited by 119
Effect of Calcitriol on Bone Loss After Cardiac or Lung Transplantation
Sambrook, P., Henderson, N. K., Keogh, A., MacDonald, P., Glanville, A., Spratt, P., Bergin, P., Ebeling, P., & Eisman, J. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.9.1818 · Cited by 119
Riggs, B. L., & NELSON, K. I. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-3-457 · Cited by 87
Bone histomorphometry in corticosteroid-induced osteoporosis and Cushing's syndrome.
Meunier, P. J., Dw, D., Edouard, C. M., Chapuy, M. C., ARLOT, M. E., & CHARHON, S. A. (1984) · PubMed · Cited by 84
Lund, B., Sørensen, O., Lund, B., & Agner, E. (1982) · Hormone and Metabolic Research · doi:10.1055/s-2007-1018990 · Cited by 81
SHIRAKI, M., KUSHIDA, K., YAMAZAKI, K., NAGAI, T., INOUE, T., & ORIMO, H. (1996) · Endocrine Journal · doi:10.1507/endocrj.43.211 · Cited by 79
Treatment of Glucocorticoid-Induced Osteoporosis with Alfacalcidol/Calcium Versus Vitamin D/Calcium
Ringe, J. D., Cöster, A., Meng, T., Schacht, E., & Umbach, R. (1999) · Calcified Tissue International · doi:10.1007/s002239900708 · Cited by 79
Stempfle, H.-U., Werner, C., Echtler, S., Wehr, U., Rambeck, W. A., Siebert, U., ??derfuhr, P., Angermann, C. E., Theisen, K., & G??rtner, R. (1999) · Transplantation · doi:10.1097/00007890-199908270-00014 · Cited by 78
Ebeling, P. R., Wark, J. D., Yeung, S., Poon, C., Salehi, N. S., Nicholson, G. C., & Kotowicz, M. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4098 · Cited by 74
Impaired Vitamin D Metabolism with Aging in Women
Tsai, K., Heath, H., Kumar, R., & Riggs, B. L. (1984) · Cited by 70
Prevention of corticosteroid-induced osteoporosis by alfacalcidol
Lakatos, P. L., Nagy, Z., Kiss, L., Horváth, C., Takács, I., Földes, J., Speer, G., & Bossányi, A. (2000) · Zeitschrift für Rheumatologie · doi:10.1007/s003930070040 · Cited by 52
Decrease of vertebral fracture in osteoporotics by administration of 1α-hydroxy-vitamin D3
Hayashi, Y., Fujita, T., & Inoue, T. (1992) · Journal of Bone and Mineral Metabolism · doi:10.1007/bf02378983 · Cited by 46
Alfacalcidol (Alpha D3) and Calcium in Osteoporosis
MENCZEL, J., FOLDES, J., STEINBERG, R., LEICHTER, I., SHALITA, B., BDOLAH-ABRAM, T., KADOSH, S., MAZOR, Z., & LADKANI, D. (1994) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-199403000-00033 · Cited by 45
Effects of chronic corticosteroid therapy on mineral metabolism and calcium absorption.
Avioli, L. V. (1984) · PubMed · Cited by 35
Clinical relevance of testosterone and dihydrotestosterone metabolism in women
Rittmaster, R. S. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80054-0 · Cited by 33
Lambrinoudaki, I. V., Chan, T. M., Lau, C. S., Wong, R. W., Yeung, S. S., & Kung, A. W. C. (2000) · PubMed · Cited by 32
Jones, G., Hogan, D. B., Yendt, E. R., & Hanley, D. A. (1996) · Europe PMC (PubMed Central) · Cited by 30
Treatment of Postmenopausal Osteoporosis with Calcitriol or Calcium
Tilyard, M., Gf, S., Thomson, J., Dovey, S. L., & Schlechte, J. (1992) · The Endocrinologist · doi:10.1097/00019616-199207000-00016 · Cited by 28
Parathyroid hormone: regulation of synthesis and secretion.
Watson, P. H., & Hanley, D. A. (1993) · PubMed · Cited by 25
Dechant, K. L., & Goa, K. L. (1994) · Drugs & Aging · doi:10.2165/00002512-199405040-00006 · Cited by 24
Efficacy of treatment of osteoporotic fractures
Eisman, J. A. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(05)80040-3 · Cited by 16
Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis
Reginster, J., Kuntz, D., Verdickt, W., Wouters, M., Guillevin, L., Menkes, C. J., & Rawlinson, D. (1997) · ORBi (University of Liège) · Cited by 5
Self-citation
Cited by
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, J. A., McCloskey, E. V., Johansson, H., Cooper, C., Rizzoli, R., Reginster, J.-Y., & on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF) (2013) · Osteoporosis International · doi:10.1007/s00198-012-2074-y · Cited by 2,948
Self-citationEuropean guidance for the diagnosis and management of osteoporosis in postmenopausal women
on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF), Kanis, J. A., Cooper, C., Rizzoli, R., & Reginster, J.-Y. (2019) · Osteoporosis International · doi:10.1007/s00198-018-4704-5 · Cited by 1,900
Self-citationNoncalcemic Actions of Vitamin D Receptor Ligands
Nagpal, S., Na, S., & Rathnachalam, R. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0002 · Cited by 961
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Kanis, J. A., Burlet, N., Cooper, C., Delmas, P. D., Reginster, J.-Y., Borgstrom, F., Rizzoli, R., & on behalf of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) (2008) · Osteoporosis International · doi:10.1007/s00198-008-0560-z · Cited by 776
Self-citationQaseem, A., Forciea, M. A., McLean, R. M., Denberg, T. D., & for the Clinical Guidelines Committee of the American College of Physicians* (2017) · Annals of Internal Medicine · doi:10.7326/m15-1361 · Cited by 676
Metadata
- Authors
- Richy, F., Ethgen, O., Bruyere, O., & Reginster, J.-Y.
- Affiliations
- University of Liège (BE)
- Corresponding author
- Richy, Florent
- Venue
- Osteoporosis International
- Published
- 2004-04-01
- Volume
- 15
- Issue
- 4
- Pages
- 301-310
- ISSN
- 0937-941X (ISSN-L)
- 1433-2965
- OpenAlex
- W1982131729
- Cited by
- 136
- References
- 67
- Citations by year
- 2025: 2 · 2024: 7 · 2023: 3 · 2022: 5 · 2021: 3 · 2020: 2 · 2019: 5 · 2018: 5 · 2017: 2 · 2016: 1 · 2015: 10 · 2014: 3 · 2013: 4 · 2012: 4
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Osteoporosis International (publishedVersion)
- PubMed (publishedVersion)
- ORBi (University of Liège) (submittedVersion)
- Funders
- Teva Pharmaceutical Industries
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin K Research Studies
- Keywords
- alfacalcidol, 1,25-dihydroxyvitamin D3, vitamin D metabolites, corticosteroid-induced osteoporosis, primary osteoporosis, bone mineral density, fracture incidence, vertebral fractures, non-vertebral fractures, bone loss prevention, calcium supplementation, treatment efficacy comparison, publication bias, study quality heterogeneity, treatment effect heterogeneity
- MeSH terms
- Adrenal Cortex Hormones, Adult, Aged, Calcitriol, Female, Humans, Hydroxycholecalciferols, Male, Middle Aged, Osteoporosis, Risk Factors, Bone Density, Randomized Controlled Trials as Topic, Spinal Fractures, Treatment Outcome, Fractures, Bone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.